Atrial pathology in cardiac amyloidosis: evidence from ECG and cardiovascular magnetic resonance.

Atrial pathology in cardiac amyloidosis: evidence from ECG and cardiovascular magnetic resonance.

Detalles Bibliográficos
Autores principales:	Leeson, C, Myerson, S, Walls, G, Neubauer, S, Ormerod, O
Formato:	Journal article
Lenguaje:	English
Publicado:	2006

Ejemplares similares

Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis
por: Roughton Michael, et al.
Publicado: (2008-11-01)

Cardiovascular Magnetic Resonance Imaging-Based Right Atrial Strain Analysis of Cardiac Amyloidosis
por: Jan Eckstein, et al.
Publicado: (2022-11-01)

Clinical and Cardiovascular Magnetic Resonance Imaging Features of Cardiac Amyloidosis
por: Marco Tana, et al.
Publicado: (2023-10-01)

The Role of Cardiovascular Magnetic Resonance Imaging in Patients with Cardiac Arrhythmias
por: Chrysovalantou Nikolaidou, et al.
Publicado: (2023-09-01)

Evaluation and management of the cardiac amyloidosis.
por: Selvanayagam, J, et al.
Publicado: (2007)

Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.
por: Cheng, A, et al.
Publicado: (2006)

Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
por: Nicola Martini, et al.
Publicado: (2020-12-01)

Myocardial triglycerides in cardiac amyloidosis assessed by proton cardiovascular magnetic resonance spectroscopy
por: Mareike Gastl, et al.
Publicado: (2019-01-01)

Diagnosis of Cardiac Involvement in Amyloid A Amyloidosis by Cardiovascular Magnetic Resonance Imaging
por: Bishwas Chamling, et al.
Publicado: (2021-09-01)

Cardiovascular magnetic resonance (CMR)--an update and review.
por: Myerson, S, et al.
Publicado: (2011)

Cardiovascular magnetic resonance (CMR) - An update and review
por: Myerson, S, et al.
Publicado: (2011)

Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging
por: Alexander Gotschy, et al.
Publicado: (2019-09-01)

Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance.
por: Petersen, SE, et al.
Publicado: (2005)

Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance
por: Petersen, SE, et al.
Publicado: (2004)

The role of cardiovascular magnetic resonance imaging in heart failure.
por: Karamitsos, T, et al.
Publicado: (2009)

Predictors of atrial emptying function in patients with hypertrophic cardiomyopathy: insights from cardiovascular magnetic resonance.
por: Tanacli, R, et al.
Publicado: (2012)

Comparison of right ventricular involvement in AL and transthyretin-type cardiac amyloidosis by cardiovascular magnetic resonance
por: Tripp Kenneth, et al.
Publicado: (2009-01-01)

The prognostic ability of aortic regurgitation quantification with cardiovascular magnetic resonance
por: Myerson, S, et al.
Publicado: (2008)

Prevalance of non-cardiac pathology on cardiovascular magnetic resonance studies
por: Pennell Dudley, et al.
Publicado: (2011-02-01)

Left atrial volumes in health and disease measured using cardiac magnetic resonance
por: Wijesurendra, R, et al.
Publicado: (2017)

Direct and indirect quantification of mitral regurgitation with cardiovascular magnetic resonance, and the effect of heart rate variability.
por: Myerson, S, et al.
Publicado: (2010)

Stress perfusion imaging using cardiovascular magnetic resonance: a review.
por: Christiansen, J, et al.
Publicado: (2010)

Predictors of atrial emptying function in patients with hypertrophic cardiomyopathy: insights from cardiovascular magnetic resonance
por: Tanacli Radu, et al.
Publicado: (2012-02-01)

Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study
por: Cassady Palmer, et al.
Publicado: (2022-01-01)

Heart valve disease: investigation by cardiovascular magnetic resonance.
por: Myerson, S
Publicado: (2012)

Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance.
por: Karamitsos, T, et al.
Publicado: (2010)

Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis and hypertrophic cardiomyopathy
por: Shan Huang, et al.
Publicado: (2022-05-01)

Treatment Response Evaluation of Cardiac Amyloidosis Using Serial T1- and T2-Mapping Cardiovascular Magnetic Resonance Imaging
por: Jinwoo Son, et al.
Publicado: (2021-03-01)

Myocardial Deformation in Cardiac Amyloid Light-chain Amyloidosis: Assessed with 3T Cardiovascular Magnetic Resonance Feature Tracking
por: Rui Li, et al.
Publicado: (2017-06-01)

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis
por: Karamitsos, T, et al.
Publicado: (2013)

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
por: Karamitsos, T, et al.
Publicado: (2013)

Feature tracking cardiac magnetic resonance in systemic light chain amyloidosis
por: Kammerer Rebekka, et al.
Publicado: (2013-01-01)

Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis.
por: Zsofia Dohy, et al.
Publicado: (2022-01-01)

Cardiac amyloidosis: Diagnosis using delayed enhancement cardiac magnetic resonance imaging sequences
por: Dinis Mesquita, et al.
Publicado: (2013-11-01)

Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imaging.
por: Cahill, T, et al.
Publicado: (2011)

The role of cardiovascular magnetic resonance in the evaluation of valve disease.
por: Karamitsos, T, et al.
Publicado: (2011)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Mathijs O. Versteylen, et al.
Publicado: (2022-07-01)

Erratum: Evaluation and management of the cardiac amyloidosis (Journal of the American College of Cardiology (2007) 50: (2101-2110))
por: Selvanayagam, J, et al.
Publicado: (2011)

Cardiac magnetic resonance spectroscopy.
por: Neubauer, S
Publicado: (2003)

Heart valve disease: investigation by cardiovascular magnetic resonance
por: Myerson Saul G
Publicado: (2012-01-01)